{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:09:48Z","timestamp":1790633388095,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Top Talent of Changzhou \u201cThe 14th Five-Year Plan\u201d High-Level Health Talents Training Project","award":["2022CZBJ051"],"award-info":[{"award-number":["2022CZBJ051"]}]},{"name":"The Clinical Research Project of Changzhou Medical Center of Nanjing Medical University","award":["CMCC202309"],"award-info":[{"award-number":["CMCC202309"]}]},{"name":"The Science and Technology Project of Changzhou Health Commission","award":["ZD202336"],"award-info":[{"award-number":["ZD202336"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-85628-5","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T17:57:23Z","timestamp":1736445443000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Safety and effectiveness of dual therapy for Helicobacter pylori infection and the effect on the glycated hemoglobin level in type 2 diabetes"],"prefix":"10.1038","volume":"15","author":[{"given":"Jie","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhou","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangrong","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,9]]},"reference":[{"key":"85628_CR1","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1007\/s10620-020-06193-7","volume":"65","author":"B Guevara","year":"2020","unstructured":"Guevara, B. & Cogdill, A. G. Helicobacter pylori: A review of current diagnostic and management strategies. Dig. Dis. Sci. 65, 1917\u20131931. https:\/\/doi.org\/10.1007\/s10620-020-06193-7 (2020).","journal-title":"Dig. Dis. Sci."},{"key":"85628_CR2","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1053\/j.gastro.2017.04.022","volume":"153","author":"JKY Hooi","year":"2017","unstructured":"Hooi, J. K. Y. et al. Global prevalence of Helicobacter pylori infection: Systematic review and meta-analysis. Gastroenterology 153, 420\u2013429. https:\/\/doi.org\/10.1053\/j.gastro.2017.04.022 (2017).","journal-title":"Gastroenterology"},{"key":"85628_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2024-332815","author":"R Zeng","year":"2024","unstructured":"Zeng, R., Gou, H., Lau, H. C. H. & Yu, J. Stomach microbiota in gastric cancer development and clinical implications. Gut https:\/\/doi.org\/10.1136\/gutjnl-2024-332815 (2024).","journal-title":"Gut"},{"key":"85628_CR4","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/dmrr.2677","volume":"32","author":"X Han","year":"2016","unstructured":"Han, X. et al. Helicobacter pylori infection is associated with type 2 diabetes among a middle- and old-age Chinese population. Diabetes Metab. Res. Rev. 32, 95\u2013101. https:\/\/doi.org\/10.1002\/dmrr.2677 (2016).","journal-title":"Diabetes Metab. Res. Rev."},{"key":"85628_CR5","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/290128","volume":"2015","author":"Y Kayar","year":"2015","unstructured":"Kayar, Y. et al. Relationship between Helicobacter pylori infections in diabetic patients and inflammations, metabolic syndrome, and complications. Int. J. Chronic Dis. 2015, 290128. https:\/\/doi.org\/10.1155\/2015\/290128 (2015).","journal-title":"Int. J. Chronic Dis."},{"key":"85628_CR6","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.4103\/0366-6999.245269","volume":"131","author":"Y Shi","year":"2018","unstructured":"Shi, Y. et al. Helicobacter pylori infection is associated with occurrence of proteinuria in type 2 diabetes patients: A systemic review and meta-analysis. Chin. Med. J. (Engl) 131, 2734\u20132740. https:\/\/doi.org\/10.4103\/0366-6999.245269 (2018).","journal-title":"Chin. Med. J. (Engl)"},{"key":"85628_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3109\/07435800.2013.794426","volume":"39","author":"F Wang","year":"2014","unstructured":"Wang, F., Fu, Y. & Lv, Z. Association of Helicobacter pylori infection with diabetic complications: A meta-analysis. Endocr. Res. 39, 7\u201312. https:\/\/doi.org\/10.3109\/07435800.2013.794426 (2014).","journal-title":"Endocr. Res."},{"key":"85628_CR8","doi-asserted-by":"publisher","first-page":"147916412095362","DOI":"10.1177\/1479164120953626","volume":"17","author":"YF Yang","year":"2020","unstructured":"Yang, Y. F. et al. Relation of Helicobacter pylori infection to peripheral arterial stiffness and 10-year cardiovascular risk in subjects with diabetes mellitus. Diab. Vasc Dis. Res. 17, 1479164120953626. https:\/\/doi.org\/10.1177\/1479164120953626 (2020).","journal-title":"Diab. Vasc Dis. Res."},{"key":"85628_CR9","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12781","volume":"26","author":"X Song","year":"2021","unstructured":"Song, X., Cai, C., Jin, Q., Chen, X. & Yu, C. The efficacy of Helicobacter pylori eradication in diabetics and its effect on glycemic control: A systematic review and meta-analysis. Helicobacter 26, e12781. https:\/\/doi.org\/10.1111\/hel.12781 (2021).","journal-title":"Helicobacter"},{"issue":"2","key":"85628_CR10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ajg.2013.03.002","volume":"14","author":"J Vafaeimanesh","year":"2013","unstructured":"Vafaeimanesh, J. et al. Effect of Helicobacter pylori eradication on glycaemia control in patients with type 2 diabetes mellitus and comparison of two therapeutic regimens. Arab J. Gastroenterol. 14(2), 55\u20138. https:\/\/doi.org\/10.1016\/j.ajg.2013.03.002 (2013).","journal-title":"Arab J. Gastroenterol."},{"key":"85628_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-327745","author":"P Malfertheiner","year":"2022","unstructured":"Malfertheiner, P. et al. Management of Helicobacter pylori infection: the Maastricht VI\/Florence consensus report. Gut https:\/\/doi.org\/10.1136\/gutjnl-2022-327745 (2022).","journal-title":"Gut"},{"key":"85628_CR12","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1097\/cm9.0000000000002546","volume":"135","author":"L Zhou","year":"2022","unstructured":"Zhou, L. et al. 2022 Chinese national clinical practice guideline on Helicobacter pylori eradication treatment. Chin. Med. J. (Engl) 135, 2899\u20132910. https:\/\/doi.org\/10.1097\/cm9.0000000000002546 (2022).","journal-title":"Chin. Med. J. (Engl)"},{"key":"85628_CR13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1159\/000236024","volume":"82","author":"M Demir","year":"2010","unstructured":"Demir, M., G\u00f6kt\u00fcrk, S., Ozt\u00fcrk, N. A., Serin, E. & Yilmaz, U. Bismuth-based first-line therapy for Helicobacter pylori eradication in type 2 diabetes mellitus patients. Digestion 82, 47\u201353. https:\/\/doi.org\/10.1159\/000236024 (2010).","journal-title":"Digestion"},{"key":"85628_CR14","doi-asserted-by":"publisher","first-page":"209","DOI":"10.26442\/00403660.2022.02.201372","volume":"94","author":"IV Maev","year":"2022","unstructured":"Maev, I. V., Mkrtumyan, A. M., Bektemirova, L. G., Andreev, D. N. & Dicheva, D. T. The effectiveness of eradication therapy of the 1st line of Helicobacter pylori infection in patients with type 2 diabetes mellitus. Ter. Arkh. 94, 209\u2013215. https:\/\/doi.org\/10.26442\/00403660.2022.02.201372 (2022).","journal-title":"Ter. Arkh."},{"key":"85628_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ajg.2013.03.002","volume":"14","author":"J Vafaeimanesh","year":"2013","unstructured":"Vafaeimanesh, J. et al. Effect of Helicobacter pylori eradication on glycaemia control in patients with type 2 diabetes mellitus and comparison of two therapeutic regimens. Arab J. Gastroenterol. 14, 55\u201358. https:\/\/doi.org\/10.1016\/j.ajg.2013.03.002 (2013).","journal-title":"Arab J. Gastroenterol."},{"key":"85628_CR16","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.1007\/s10238-023-01074-5","volume":"23","author":"X Peng","year":"2023","unstructured":"Peng, X. et al. Combination of vonoprazan and amoxicillin as the first-line Helicobacter pylori eradication therapy: A multicenter, prospective, randomized, parallel-controlled study. Clin. Exp. Med. 23, 4011\u20134019. https:\/\/doi.org\/10.1007\/s10238-023-01074-5 (2023).","journal-title":"Clin. Exp. Med."},{"key":"85628_CR17","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1016\/j.cgh.2024.01.022","volume":"22","author":"X Peng","year":"2024","unstructured":"Peng, X. et al. Efficacy and safety of vonoprazan\u2013amoxicillin dual regimen with varying dose and duration for Helicobacter pylori eradication: A multicenter, prospective, randomized study. Clin. Gastroenterol. Hepatol. 22, 1210\u20131216. https:\/\/doi.org\/10.1016\/j.cgh.2024.01.022 (2024).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"85628_CR18","doi-asserted-by":"publisher","first-page":"175628482311909","DOI":"10.1177\/17562848231190976","volume":"16","author":"X Wang","year":"2023","unstructured":"Wang, X., Teng, G., Dong, X., Dai, Y. & Wang, W. Efficacy and safety of vonoprazan\u2013amoxicillin dual therapy for Helicobacter pylori first-line treatment: A single-center, randomized, controlled trial. Therap. Adv. Gastroenterol. 16, 17562848231190976. https:\/\/doi.org\/10.1177\/17562848231190976 (2023).","journal-title":"Therap. Adv. Gastroenterol."},{"key":"85628_CR19","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.3748\/wjg.v29.i20.3133","volume":"29","author":"J Yu","year":"2023","unstructured":"Yu, J. et al. Safety and effectiveness of vonoprazan-based rescue therapy for Helicobacter pylori infection. World J. Gastroenterol. 29, 3133\u20133144. https:\/\/doi.org\/10.3748\/wjg.v29.i20.3133 (2023).","journal-title":"World J. Gastroenterol."},{"key":"85628_CR20","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.3748\/wjg.v9.i5.1126","volume":"9","author":"M Sarg\u00fdn","year":"2003","unstructured":"Sarg\u00fdn, M. et al. Type 2 diabetes mellitus affects eradication rate of Helicobacter pylori. World J. Gastroenterol. 9, 1126\u20131128. https:\/\/doi.org\/10.3748\/wjg.v9.i5.1126 (2003).","journal-title":"World J. Gastroenterol."},{"key":"85628_CR21","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.2147\/idr.S194584","volume":"12","author":"CC Yao","year":"2019","unstructured":"Yao, C. C. et al. First-line Helicobacter pylori eradication rates are significantly lower in patients with than those without type 2 diabetes mellitus. Infect. Drug Resist. 12, 1425\u20131431. https:\/\/doi.org\/10.2147\/idr.S194584 (2019).","journal-title":"Infect. Drug Resist."},{"key":"85628_CR22","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1136\/gutjnl-2021-324032","volume":"70","author":"F Megraud","year":"2021","unstructured":"Megraud, F. et al. Helicobacter pylori resistance to antibiotics in Europe in 2018 and its relationship to antibiotic consumption in the community. Gut 70, 1815\u20131822. https:\/\/doi.org\/10.1136\/gutjnl-2021-324032 (2021).","journal-title":"Gut"},{"key":"85628_CR23","doi-asserted-by":"publisher","first-page":"546","DOI":"10.4103\/2230-8210.183480","volume":"20","author":"A Chawla","year":"2016","unstructured":"Chawla, A., Chawla, R. & Jaggi, S. Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum?. Indian J. Endocrinol. Metab. 20, 546\u2013551. https:\/\/doi.org\/10.4103\/2230-8210.183480 (2016).","journal-title":"Indian J. Endocrinol. Metab."},{"issue":"780","key":"85628_CR24","doi-asserted-by":"publisher","first-page":"e785","DOI":"10.1016\/j.cmi.2017.11.010","volume":"24","author":"DS Liu","year":"2018","unstructured":"Liu, D. S. et al. Primary antibiotic resistance of Helicobacter pylori in Chinese patients: A multiregion prospective 7-year study. Clin. Microbiol. Infect. 24(780), e785-780.e788. https:\/\/doi.org\/10.1016\/j.cmi.2017.11.010 (2018).","journal-title":"Clin. Microbiol. Infect."},{"key":"85628_CR25","doi-asserted-by":"publisher","first-page":"803","DOI":"10.14309\/ajg.0000000000002714","volume":"119","author":"Q Zhuang","year":"2024","unstructured":"Zhuang, Q. et al. Comparative efficacy of P-CAB vs proton pump inhibitors for grade C\/D esophagitis: A systematic review and network meta-analysis. Am. J. Gastroenterol. 119, 803\u2013813. https:\/\/doi.org\/10.14309\/ajg.0000000000002714 (2024).","journal-title":"Am. J. Gastroenterol."},{"key":"85628_CR26","doi-asserted-by":"publisher","first-page":"205031211983209","DOI":"10.1177\/2050312119832093","volume":"7","author":"SJ Nam","year":"2019","unstructured":"Nam, S. J. et al. Helicobacter pylori eradication in patients with type 2 diabetes mellitus: Multicenter prospective observational study. SAGE Open Med. 7, 2050312119832093. https:\/\/doi.org\/10.1177\/2050312119832093 (2019).","journal-title":"SAGE Open Med."},{"key":"85628_CR27","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.amjms.2015.11.011","volume":"351","author":"N Jafar","year":"2016","unstructured":"Jafar, N., Edriss, H. & Nugent, K. The effect of short-term hyperglycemia on the innate immune system. Am. J. Med. Sci. 351, 201\u2013211. https:\/\/doi.org\/10.1016\/j.amjms.2015.11.011 (2016).","journal-title":"Am. J. Med. Sci."},{"key":"85628_CR28","doi-asserted-by":"publisher","first-page":"G1037","DOI":"10.1152\/ajpgi.1991.261.6.G1037","volume":"261","author":"K Endoh","year":"1991","unstructured":"Endoh, K., Kauffman, G. L. Jr. & Leung, F. W. Mechanism of aggravation of mucosal injury by intravenous nicotine in rat stomach. Am. J. Physiol. 261, G1037-1042. https:\/\/doi.org\/10.1152\/ajpgi.1991.261.6.G1037 (1991).","journal-title":"Am. J. Physiol."},{"key":"85628_CR29","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1136\/gut.26.12.1327","volume":"26","author":"F Parente","year":"1985","unstructured":"Parente, F., Lazzaroni, M., Sangaletti, O., Baroni, S. & Bianchi Porro, G. Cigarette smoking, gastric acid secretion, and serum pepsinogen I concentrations in duodenal ulcer patients. Gut 26, 1327\u20131332. https:\/\/doi.org\/10.1136\/gut.26.12.1327 (1985).","journal-title":"Gut"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85628-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85628-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85628-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T18:04:51Z","timestamp":1736445891000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85628-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,9]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["85628"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-85628-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,9]]},"assertion":[{"value":"8 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1537"}}